Search Results - "Fabbroni, Marta"

  • Showing 1 - 20 results of 20
Refine Results
  1. 1

    Drug Retention Rates and Treatment Discontinuation among Anti-TNF-α Agents in Psoriatic Arthritis and Ankylosing Spondylitis in Clinical Practice by Galeazzi, Mauro, Frediani, Bruno, Pagano, Veronica Anna, Costa, Luisa, Caso, Francesco, Cantarini, Luca, Fabbroni, Marta, Manganelli, Stefania

    Published in Mediators of Inflammation (01-01-2014)
    “…Objective. The study aim was to determine treatment persistence rates and to identify causes of discontinuation in psoriatic arthritis (PsA) and ankylosing…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Treatment of erosive osteoarthritis of the hands by intra-articular infliximab injections: a pilot study by Fioravanti, Antonella, Fabbroni, Marta, Cerase, Alfonso, Galeazzi, Mauro

    Published in Rheumatology international (01-06-2009)
    “…Our pilot study aimed to investigate the efficacy and tolerability of intra-articular (i.a.) injections of infliximab as a therapy for erosive osteoarthritis…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    Intravenous Immunoglobulins as a new opportunity to treat discoid lupus erythematosus: A case report and review of the literature by Tenti, Sara, Fabbroni, Marta, Mancini, Virginia, Russo, Filomena, Galeazzi, Mauro, Fioravanti, Antonella

    Published in Autoimmunity reviews (01-08-2018)
    “…Discoid lupus erythematosus (DLE) is a chronic dermatological disease that can lead to scarring, alopecia and dyspigmentation, if not properly treated…”
    Get more information
    Journal Article
  8. 8
  9. 9

    Intravenous Immunoglobulins as a new opportunity to treat discoid lupus erythematosus by Tenti, Sara, Fabbroni, Marta, Mancini, Virginia, Russo, Filomena, Galeazzi, Mauro, Fioravanti, Antonella

    Published in Autoimmunity reviews (01-08-2018)
    “…Discoid lupus erythematosus (DLE) is a chronic dermatological disease that can lead to scarring, alopecia and dyspigmentation, if not properly treated…”
    Get full text
    Journal Article
  10. 10

    Magnetic resonance imaging of the sacroiliac joints in SpA: with or without intravenous contrast media? A preliminary report by Gentili, Francesco, Cantarini, Luca, Fabbroni, Marta, Nigri, Aandrea, Mazzei, Francesco Giuseppe, Frediani, Bruno, Galeazzi, Mauro, Volterrani, Luca, Mazzei, Maria Antonietta

    Published in Radiologia medica (01-11-2019)
    “…Object Active sacroiliitis based on magnetic resonance imaging (MRI) without intravenous (I.V.) contrast material injection is considered sufficient for the…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Cartilage oligomeric matrix protein level in rheumatic diseases: potential use as a marker for measuring articular cartilage damage and/or the therapeutic efficacy of treatments by Morozzi, Gabriella, Fabbroni, Marta, Bellisai, Francesca, Pucci, Gabriella, Galeazzi, Mauro

    Published in Annals of the New York Academy of Sciences (01-06-2007)
    “…Cartilage oligomeric matrix protein (COMP) is a tissue-specific noncollagenous protein that was first detected in the serum and the synovial fluid of patients…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    Effects of tumor necrosis factor-α inhibitors in mothers and daughters concordant for HLA-B27-positive ankylosing spondylitis by Caso, Francesco, Costa, Luisa, Del Puente, Antonio, Rigante, Donato, Selmi, Carlo, Fabbroni, Marta, Scarpa, Raffaele, Galeazzi, Mauro, Frediani, Bruno, Cantarini, Luca

    Published in Clinical and experimental rheumatology (01-05-2015)
    “…Pharmacogenomics is considered as the new frontier to predict the response to treatments and it can also be based on the comparison of family members being…”
    Get full text
    Journal Article
  17. 17

    Cartilage Oligomeric Matrix Protein Level in Rheumatic Diseases by MOROZZI, GABRIELLA, FABBRONI, MARTA, BELLISAI, FRANCESCA, PUCCI, GABRIELLA, GALEAZZI, MAURO

    Published in Annals of the New York Academy of Sciences (01-06-2007)
    “…:  Cartilage oligomeric matrix protein (COMP) is a tissue‐specific noncollagenous protein that was first detected in the serum and the synovial fluid of…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20